Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01825057 · ClinicalTrials.gov registry record · NA

Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units

A NA study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
1,211
Enrollment target

NCT01825057: Completed NA study, sponsored by National Institute on Drug Abuse (NIDA).

NCT01825057 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 1,211 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01825057, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
1,211 participants
Enrollment target

Study Summary

General medical hospitals provide care for a disproportionate share of patients who misuse substances. Motivational interviewing (MI) is a well-recognized, evidenced-based substance use treatment. However, it is unclear which implementation strategies lead to the efficient and proficient uptake of MI in general medical settings, such as medical inpatient units. Because medical providers have multiple practice demands and time constraints, new practices have the greatest chance of being implemented if they are simple and compatible with existing workflows and systems. Two widely used strategies to bring specialized practices into use within general hospital settings are the apprenticeship model of training and use of consultation-liaison (CL) services. The apprenticeship model requires that appropriate patients and trainers are available with high flexibility for teaching and supervision; when applied to behavioral counseling approaches, this model may be incompatible with the providers' medical role and time constraints. In contrast, ordering MI through CL is relatively simple, minimally burdensome, and highly compatible with the way clinicians secure other specialist services for their patients in the hospital. This cluster randomized controlled trial examines the effectiveness of three different strategies for integrating MI into the practice of medical providers working within an academically affiliated internal medicine hospitalist service. Specifically, the trial randomizes 38 healthcare providers to one of three conditions: (1) a continuing medical education workshop that provides background and "shows" healthcare providers how to conduct MI (the control condition, called SEE ONE); (2) a "see one, do one" apprenticeship model involving workshop training plus live supervision of bedside practice (DO ONE); and (3) ordering MI from CL after learning about it in a workshop (ORDER ONE). Following the respective MI trainings, each healthcare provider will be assesse

Primary Outcome

The percentage of audio recorded Motivational Interviewing sessions conducted by providers for their 40 consecutively enrolled study-eligible patients

Interventions

  • BEHAVIORAL See One
  • BEHAVIORAL Do One
  • BEHAVIORAL Order One

Trial Details

FieldValue
Enrollment Target 1,211 participants
Start Date 2013-02-21
Est. Completion 2019-04-25
Phase NA

What the finished NCT01825057 record still lists

NCT01825057 is an interventional study that assigns participants to a tested intervention. Its 1,211 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).

The record links to 0 conditions, and to 3 interventions - of which See One is the first listed.

NCT01825057 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01825057 about?

NCT01825057 is a clinical study titled "Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units". General medical hospitals provide care for a disproportionate share of patients who misuse substances. Motivational interviewing (MI) is a well-recognized, evidenced-based substance use treatment. However, it is unclear which implementation strategies lead to the efficient and proficient uptake of M...

What is the current status of trial NCT01825057?

This trial is currently completed. It is a NA study. The enrollment target is 1,211 participants. The study started on 2013-02-21. Estimated completion is 2019-04-25.

What interventions are being tested in trial NCT01825057?

The interventions under investigation include: See One (BEHAVIORAL), Do One (BEHAVIORAL), Order One (BEHAVIORAL).

Who is sponsoring clinical trial NCT01825057?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01825057's enrollment target sits among peer trials

1,211 83rd of 2000 higher than 1,918 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04267848 · 1,210 participants · Phase 3

    Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • NCT05946213 · 1,209 participants · Phase 3

    Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • NCT05827016 · 1,216 participants · Phase 3

    A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

  • NCT06143956 · 1,217 participants · Phase 2

    A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01825057, the US trial registry maintained by the National Library of Medicine. NCT01825057 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.